Skip to content

Clinical trials

Phase 3 Neuralgia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 3 Country / region: Germany Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20121
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Terminated2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Apurano Pharmaceuticals GmbH4
Grünenthal GmbH1
MedtronicNeuro1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia7
Agnosia5
Chronic Pain5
Pain5
Marijuana Abuse4
Somatoform Disorders4
Brain Injuries, Traumatic2
Multiple Sclerosis2
Paraplegia2
Peripheral Nerve Injuries2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.